BREANNE MILES: Open Payments
NPI 1275057358 · CANTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$518 in 29 payments from 11 companies in 2025. Trend: 2023 $17 · 2024 $353 · 2025 $518
Food & beverage: $518
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $155 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| PFIZER INC. | 3 | $50 |
| Lilly USA, LLC | 3 | $45 |
| Amgen Inc. | 3 | $43 |
| Astellas Pharma US Inc | 2 | $42 |
| Novo Nordisk Inc | 2 | $35 |
| Corium, LLC | 1 | $32 |
| Exact Sciences Corporation | 2 | $29 |
| Tris Pharma Inc | 1 | $26 |
Products named: AIRSUPRA, FARXIGA, TRELEGY ELLIPTA, ELIQUIS, OTEZLA, Veozah, Ozempic, Azstarys.
Industry payments across TX — which companies pay providers there.
